GLP-1 weight loss claims on TikTok: separating hype from data

What did @sunnykai25 actually say?

Nothing about GLP-1 medications. Not one word. The entire transcript is a loose, partially misremembered rendition of "Every Breath You Take" by The Police, the 1983 Sting classic. The creator sings lines like "every breath you take, every move you make" and adds their own apparent improvisation, including the puzzling sign-off "I'm a boy I think." There are zero health claims in this video.

This was categorized under GLP-1 receptor agonists, which cover drugs like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide, and retatrutide. None of those appear in the transcript. There is no mention of weight loss, blood sugar, insulin, appetite, or anything even adjacent to metabolic health. The category tag appears to be a misclassification, either by algorithm or by manual error.

Does the science back this up?

There is no scientific claim here to evaluate. The video is a song performance. "Every Breath You Take" has not, to this writer's knowledge, been studied in any randomized controlled trial for its effects on GLP-1 secretion, though the research gap is noted.

If we stretch to ask whether music-related content can intersect with GLP-1 medication spaces in meaningful ways, sure, there is growing literature on behavioral and psychological components of weight management. A 2022 paper by Wharton et al. in Obesity Reviews noted that emotional regulation strategies, including creative expression, can support adherence to obesity treatment programs. But applying that to this video would be a significant reach. The creator is singing. That is the full extent of the health-relevant activity here.

What did they get wrong (or right)?

The creator got the song lyrics partially wrong. The original lyric is "Oh, can't you see" not "oh can't you sing." The line "I'm a boy I think" does not appear anywhere in the Sting discography. These are not medically significant errors, but they are errors.

From a health communication standpoint, there is nothing to correct and nothing to praise. The creator made no medical claims. They did not recommend a drug, suggest a dose, imply a cure, or compare compounded semaglutide to branded Wegovy. In the crowded, often reckless world of GLP-1 TikTok content, a video that says absolutely nothing about GLP-1 medications is, ironically, among the least harmful things you can post in the category. That is a low bar, but @sunnykai25 cleared it without incident.

What should you actually know?

If you landed here looking for reliable GLP-1 information, here is what actually matters. GLP-1 receptor agonists are a class of medications with strong clinical evidence behind them. Semaglutide at the 2.4mg weekly dose produced average weight loss of about 15 percent of body weight in the STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine). Tirzepatide showed even larger effects, with up to 22.5 percent body weight reduction in the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine).

These are real drugs with real effects and real side effects, including nausea, vomiting, gastroparesis risk, and, in patients with a personal or family history of medullary thyroid carcinoma, potential thyroid risk. They require clinical oversight. They are not interchangeable with compounded versions, which vary in formulation and have not been subject to the same regulatory review as FDA-approved branded products. Anyone considering these medications should consult a licensed clinician, not a TikTok singing video.

Bottom line

This is a song. It was filed under GLP-1. Those two facts do not belong together. The video poses no misinformation risk because it contains no information. Misclassification of content in health categories is a real platform problem, since it can dilute the signal of actual health content and confuse both users and fact-checkers. But @sunnykai25 personally did nothing wrong here. They sang a song, got a few words wrong, and moved on. In the GLP-1 content ecosystem, that is practically a public health service.